Danaher

Danaher

Yahoo Finance • 3 days ago

Leica Biosystems Completes Acquisition of StatLab to Bolster Delivery of More Precise, Timely Diagnostics for Cancer Patients

Acquisition advances Leica Biosystems' end-to-end anatomic pathology ecosystem, expanding integrated solutions that help laboratories move from sample to answer with speed and confidence for the clinicians and patients who depend on them... Full story

Yahoo Finance • 7 days ago

TDM Reagent Kit Market Forecasts Growth from $2.87B (2026) to $6.96B by 2032, Profiling Abbott, Roche, Danaher, Siemens Healthineers & Thermo Fisher

Company Logo Opportunities center on automated, standardized TDM kits integrated with AI dosing tools for antimicrobial stewardship, transplant care and precision medicine, especially in Asia-Pacific. Dublin, Sept. 24, 2026 (GLOBE NEWSWI... Full story

Yahoo Finance • 8 days ago

GE HealthCare (GEHC) is Down 28% and Wall Street is Starting to Buy. Is the Selloff Finally Over?

GE HealthCare Technologies Inc. (NASDAQ:GEHC) specializes in hospital imaging, including MRI, CT, and ultrasound machines, and the contrast agents required to interpret scans. Spun out of General Electric in early 2023, GE HealthCare trade... Full story

Yahoo Finance • 8 days ago

Global Pharmaceutical Filtration Report: Biologics Manufacturing Shifts as Danaher, Merck KGaA, Sartorius, 3M and Thermo Fisher Reshape the Market

Company Logo Biologics, stricter purity rules and flexible manufacturing are driving demand for single-use, automated and continuous filtration, advanced membranes and sustainable systems. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Phar... Full story

Yahoo Finance • 8 days ago

Bioreactors Market Outlook 2026-2035 - Featuring Profiles of 3 Leading Companies: Sartorius, Thermo Fisher Scientific, and Danaher

Company Logo Bioreactors Market Gains Momentum as Single-Use Systems, Automation and Advanced Therapies Reshape Biomanufacturing Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Bioreactors Market Opportunity, Growth Drivers, Industry Trend A... Full story

Yahoo Finance • 9 days ago

Capitalize on the Label-Free Detection Market Shift: Track How Danaher, Sartorius, Agilent, Bruker and Revvity Are Disrupting R&D ROI and Reshaping Global Revenue Through 2030

Company Logo AI-enabled, microfluidic label-free detection is expanding in drug discovery, early diagnostics, food safety and environmental testing, driven by efficient, non-invasive, sustainable workflows. Dublin, Sept. 22, 2026 (GLOBE... Full story

Yahoo Finance • 9 days ago

Capitalize on the Aseptic Sampling Shift: Benchmark Merck KGaA, Sartorius, Thermo Fisher Scientific, Danaher and GEA to Secure Bioprocessing ROI Across the Forecast Period

Company Logo Demand is rising for single-use, automated and real-time aseptic sampling as biopharma and food producers prioritize contamination control, continuous manufacturing and compliance. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) --... Full story

Yahoo Finance • 9 days ago

Capitalize on High Content Screening Disruption: Decode How Thermo Fisher Scientific, Danaher, Revvity, and Yokogawa Are Reshaping Global R&D ROI and Revenue

Company Logo High-content screening is advancing drug discovery and personalized medicine, driven by 3D models, advanced imaging and automated analytics, with opportunities in cancer research and organoids. Dublin, Sept. 22, 2026 (GLOBE... Full story

Yahoo Finance • 13 days ago

2 Unpopular Stocks That Should Get More Attention and 1 We Question

2 Unpopular Stocks That Should Get More Attention and 1 We Question Wall Street's bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate... Full story

Yahoo Finance • 15 days ago

Point of Care Diagnostics Market Forecasts Growth from $20.63B (2026) to $31.46B by 2031, Profiling QuidelOrtho, Sysmex, HemoCue, Trinity Biotech & 15 Other Key Players

Company Logo The global point-of-care diagnostics market is projected to grow from USD 20.63 billion in 2026 to USD 31.46 billion by 2031, at an 8.8% CAGR. Growth is driven by demand for rapid, accurate and decentralized testing, alongsid... Full story

Yahoo Finance • 16 days ago

Danaher Announces Quarterly Dividend

WASHINGTON, Sept. 15, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on October 30, 2026 to ho... Full story

Yahoo Finance • 16 days ago

Single-Use Bioreactors Market by Product, Type, Cell Type, Molecule, Process Mode, Application, Competition, Region - Global Forecast to 2031

Company Logo The global single-use bioreactors market is forecast to grow from USD 5.43 billion in 2026 to USD 9.58 billion by 2031, at a 12.0% CAGR. Growth is driven by biologics, biosimilars, vaccine manufacturing, CDMO outsourcing, and... Full story

Yahoo Finance • 23 days ago

Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others

Company Logo 500-Page Report Spans 450 Data Tables Across Product, Species, Host Cell, and Application Segments as Human Recombinant Proteins Lead Demand Research Use Recombinant Protein MarketResearch Use Recombinant Protein Market Dub... Full story

Yahoo Finance • 27 days ago

Is Revvity Stock a Buy as Growth Improves but Valuation Stays Rich?

Revvity, Inc. RVTY is entering the second half of 2026 with stronger operating momentum. Raised guidance, double-digit Diagnostics growth and better cash generation have improved the earnings setup. The counterweight is valuation. RVTY al... Full story

Yahoo Finance • 28 days ago

Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?

It has been about a month since the last earnings report for Pediatrix Medical Group (MD). Shares have added about 3.4% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent positive trend cont... Full story

Yahoo Finance • 28 days ago

Danaher (DHR) Seen Deftly Navigating AI Integration

Eagle Capital Management, an investment management company, released its second quarter 2026 investor letter. A copy of the letter can be downloaded here. In the quarter, Eagle Capital Management discussed how enthusiasm around AI capital... Full story

Yahoo Finance • last month

Why Danaher (DHR) Remains a Healthcare Compounder to Watch

Aristotle Capital Management, LLC, an investment management company, released its "Value Equity Fund" Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund delivered a 4.32% total return in Q2 2026, underperforming... Full story

Yahoo Finance • last month

3 Industrials Stocks with Questionable Fundamentals

3 Industrials Stocks with Questionable Fundamentals Even if they go mostly unnoticed, industrial businesses are the backbone of our country. But they are at the whim of volatile macroeconomic factors that influence capital spending (like... Full story

Yahoo Finance • last month

Danaher Rides on Strength in Biotechnology Segment: Will It Sustain?

Danaher Corporation's DHR Biotechnology segment continues to be a key contributor to its growth. In the second quarter of 2026, the segment's reported sales rose 4% year over year to $1.92 billion. Also, its core revenues increased 2.5% on... Full story

Yahoo Finance • last month

Masimo Receives FDA 510(k) Clearance for Root® with LiDCO® and the Masimo LiDCO Sensor to Provide Continuous Oxygen Delivery (DO₂)

The Power of LiDCO Hemodynamic Monitoring, Noninvasive Hemoglobin (SpHb®), and Masimo SET® Pulse Oximetry Brings Continuous, Beat-to-Beat Assessment of Oxygen Delivery IRVINE, Calif., Aug. 25, 2026 /PRNewswire/ -- Masimo, a Danaher compan... Full story